Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | SRD5A1 | P18405 | 5/20 | 0.32 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.32 |
| ▸ | UBE2M | P61081 | 1/20 | 0.31 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.31 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.30 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.30 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21881689 | 0.88 | SRD5A1 (0.31) | ADH1CADH1AADH4SRD5A1UBE2M | |
| SCHEMBL28406573 | 0.85 | UBE2M (0.36) | ADH1CADH1AADH4SRD5A1UBE2M | |
| SCHEMBL28398909 | 0.85 | UBE2M (0.36) | ADH1CADH1AADH4SRD5A1UBE2M | |
| SCHEMBL28397553 | 0.85 | UBE2M (0.36) | ADH1CADH1AADH4SRD5A1UBE2M | |
| SCHEMBL10721655 | 0.83 | BCHE (0.33) | ADH1CADH1AADH4SRD5A1SRD5A2 | |
| SCHEMBL28405051 | 0.83 | UBE2M (0.36) | ADH1CADH1AADH4SRD5A1SRD5A2 | |
| SCHEMBL13246442 | 0.79 | UBE2M (0.32) | ADH1CADH1AADH4SRD5A1UBE2M | |
| SCHEMBL8849264 | 0.79 | L3MBTL1 (0.33) | SRD5A1UBE2MDCUN1D1 | |
| SCHEMBL9421811 | 0.79 | L3MBTL1 (0.33) | SRD5A1UBE2MDCUN1D1 | |
| SCHEMBL28407156 | 0.79 | UBE2M (0.37) | SRD5A1UBE2MDCUN1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2758462-B1 | STABILIZING OF ORGANIC MATERIAL WITH AMINO-TRIAZINE BASED MANNICH-COMPOUNDS | BOREALIS AG (AT) | 2018-03-07 | — | — | EP | disclosed |
| US-9546261-B2 | Stabilizing of organic material with amino-triazine based mannich-compounds | BOREALIS AG (AT) | 2017-01-17 | — | — | US | disclosed |
| US-20140235766-A1 | Stabilizing of Organic Material with Amino-Triazine Based Mannich-Compounds | BOREALIS AG (AT) | 2014-08-21 | — | — | US | disclosed |
| US-20090312464-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-12-17 | — | — | US | disclosed |
| US-7332105-B2 | Synergistic UV absorber combination | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-19 | — | — | US | disclosed |
| US-7169835-B2 | Stabilizer mixture | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235766-A1 | Stabilizing of Organic Material with Amino-Triazine Based Mannich-Compounds | PCNA, SOD1, UBE2M | ADH1C 3493/4885ADH1A 3323/4885ADH4 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.